Key statistics
On Monday, NewAmsterdam Pharma Company NV (KH6:FRA) closed at 28.80, -17.71% below its 52-week high of 35.00, set on Nov 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 27.80 |
|---|---|
| High | 28.80 |
| Low | 27.80 |
| Bid | 28.80 |
| Offer | 29.60 |
| Previous close | 28.60 |
| Average volume | 87.43 |
|---|---|
| Shares outstanding | 113.39m |
| Free float | 112.86m |
| P/E (TTM) | -- |
| Market cap | 3.93bn USD |
| EPS (TTM) | -2.02 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 14:25 GMT.
More ▼
Announcements
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
- NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
- NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in November
- NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
More ▼
